Dermatofibroma
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Imeko eqhelekileyo ye Dermatofibroma ― Iqhuqhuva eliqinileyo kwilungu. Dermatofibroma lithumba eliyingozi elixhaphakileyo.
References
Dermatofibroma yimeko yesikhumba eqhelekileyo efumaneka kakhulu ezingalweni okanye emilenzeni. Ibonakala njengamaqhuma aqinileyo phantsi kwesikhumba, amaxesha amaninzi ngaphantsi kwe-1 centimeter ngobukhulu. Ngelixa ihlala ingenantlungu, inokunxulunyaniswa nokonzakala okuncinci okudlulileyo okufana nokulunywa zizinambuzane okanye ukuhlatywa ngameva. I-dermatofibromas inokuchaphazela nabani na kodwa ixhaphake kakhulu kwabasetyhini abaneminyaka engama-20 ukuya kuma-40. Kubalulekile ukwahlula idermatofibromas kwithumba lolusu elinobundlobongela elibizwa ngokuba dermatofibrosarcoma protuberans.
Dermatofibroma is a commonly occurring cutaneous entity usually centered within the skin's dermis. Dermatofibromas are referred to as benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, or common fibrous histiocytoma. These mesenchymal cell lesions of the dermis clinically are firm subcutaneous nodules that occur on the extremities in the vast majority of cases and may or may not be associated with overlying skin changes. They are most commonly asymptomatic and usually relatively small, less than or equal to 1 centimeter in diameter. Often, patients who present with a dermatofibroma relate a history of possibly inciting local trauma at the site, such as from an insect bite or superficial puncture wound from thorns or wood splinters. Dermatofibromas occur in people of all ages, although more commonly during the ages of the 20s to 40s, and develop more frequently in females than males, with as high as a 2:1 female to male predominance according to some reports. They are a benign tumor, although there have been cases of local recurrence, and even more rarely, distant metastases have been reported. When considering the differential diagnosis of these lesions, it is vitally important to distinguish dermatofibromas from dermatofibrosarcoma protuberans, a similar-appearing but more aggressive cutaneous neoplasm.
Dermatofibroma is a commonly occurring cutaneous entity usually centered within the skin's dermis. Dermatofibromas are referred to as benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, or common fibrous histiocytoma. These mesenchymal cell lesions of the dermis clinically are firm subcutaneous nodules that occur on the extremities in the vast majority of cases and may or may not be associated with overlying skin changes. They are most commonly asymptomatic and usually relatively small, less than or equal to 1 centimeter in diameter. Often, patients who present with a dermatofibroma relate a history of possibly inciting local trauma at the site, such as from an insect bite or superficial puncture wound from thorns or wood splinters. Dermatofibromas occur in people of all ages, although more commonly during the ages of the 20s to 40s, and develop more frequently in females than males, with as high as a 2:1 female to male predominance according to some reports. They are a benign tumor, although there have been cases of local recurrence, and even more rarely, distant metastases have been reported. When considering the differential diagnosis of these lesions, it is vitally important to distinguish dermatofibromas from dermatofibrosarcoma protuberans, a similar-appearing but more aggressive cutaneous neoplasm.
Unyango olukhethwayo lwe- lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, epidermoid cysts kukususwa ngotyando. Cherry angiomas, sebaceous hyperplasia zidla ngokunyangwa ngonyango lwelaser okanye ielectrodesiccation. Unyango lweCryotherapy kunye nokuchetywa kwetsheva lukhetho oludumileyo lwe acrochordons, seborrheic keratoses. Ukuba ugqirha wentsapho uziva engaqinisekanga malunga nokuxilongwa okanye ukunyanga isilonda, okanye ukuba i-biopsy iqinisekisa i-melanoma, ukuthunyelwa kwingcali kuyacetyiswa.
The preferred treatment for lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, epidermoid cysts is surgical removal. Cherry angiomas, sebaceous hyperplasia are commonly treated with laser therapy or electrodesiccation. Cryotherapy and shave excision are popular choices for acrochordons, seborrheic keratoses. If a family physician feels uncertain about diagnosing or treating a lesion, or if a biopsy confirms melanoma, referral to a specialist is recommended.
The preferred treatment for lipomas, dermatofibromas, keratoacanthomas, pyogenic granulomas, epidermoid cysts is surgical removal. Cherry angiomas, sebaceous hyperplasia are commonly treated with laser therapy or electrodesiccation. Cryotherapy and shave excision are popular choices for acrochordons, seborrheic keratoses. If a family physician feels uncertain about diagnosing or treating a lesion, or if a biopsy confirms melanoma, referral to a specialist is recommended.
I-Dermatofibromas inokubunjwa njengendlela yokusabela kukulimala kwangaphambili okufana nokulunywa kwezinambuzane okanye ukukhala kwameva. I-Dermatofibromas ihlelwa njengezilonda zesikhumba ezinobungozi, oku kuthetha ukuba azinabungozi ngokupheleleyo, nangona i-Dermatofibromas inokubhidaniswa kunye neentlobo zamathumba angaphantsi kwe-subcutaneous. I-dermatofibromas engena nzulu inokuba nzima ukwahlula, nakwi-histologically, ukusuka kwithumba elinqabileyo le-fibrohistocytic eliyingozi njenge "dermatofibrosarcoma protuberans".
○ Uxilongo kunye noNyango
Uninzi alunabungozi, kodwa izilonda ezinkulu (>5 mm) zinokufuna i-biopsy.
#Dermoscopy
#Skin biopsy